Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Faucher

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Leukemia & Lymphoma|June 19, 2012
Poor autologous mobilization status does not impact on hematological recovery but affects outcome after allogeneic stem cell transplant for lymphoma and myelomaRoberto Crocchiolo, Christian Chabannon, Jean El-Cheikh, et al.
Bulletin Du Cancer|December 25, 2018
[Stem cell transplantation unit: Guidelines from the francophone Society of bone marrow transplantation and cellular therapy (SFGM-TC)]Catherine Faucher, Catherine Adam, Nelly Bancillon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2018
HLA-Matched Sibling versus Unrelated versus Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leukemia: A Single-Center Donor ComparisonRaynier Devillier, Faezeh Legrand, Jérôme Rey, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 26, 2019
Peripheral Blood Stem Cells versus Bone Marrow for T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Hodgkin LymphomaJacopo Mariotti, Raynier Devillier, Stefania Bramanti, et al.
Bulletin Du Cancer|May 16, 2024
[Haematopoietic stem cell donation from minor donor: Respecting laws, assessing fitness, delivering information and good care (SFGM-TC)]Marie Lejeune, Bertille Menard, Sophie Servais, et al.
Haematologica|July 17, 2010
Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI studyCatherine Cordonnier, Montserrat Rovira, Johan Maertens, et al.
Bone Marrow Transplantation|March 21, 2019
Peripheral blood stem cell for haploidentical transplantation with post-transplant high dose cyclophosphamide: detailed analysis of 181 consecutive patientsAngela Granata, Sabine Fürst, Stefania Bramanti, et al.
Cancer|August 16, 2012
Randomized study of 2 reduced-intensity conditioning strategies for human leukocyte antigen-matched, related allogeneic peripheral blood stem cell transplantation: prospective clinical and socioeconomic evaluationDidier Blaise, Reza Tabrizi, Jean-Marie Boher, et al.
Bulletin Du Cancer|November 28, 2017
[Indications and follow-up for autologous hematopoietic stem cell transplantation in autoimmune and autoinflammatory diseases: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Grégory Pugnet, Christina Castilla-Llorente, Mathieu Puyade, et al.
Blood|August 30, 2003
Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumorsDidier Blaise, Jacques Olivier Bay, Catherine Faucher, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Leukemia & Lymphoma|June 19, 2012
Poor autologous mobilization status does not impact on hematological recovery but affects outcome after allogeneic stem cell transplant for lymphoma and myelomaRoberto Crocchiolo, Christian Chabannon, Jean El-Cheikh, et al.
Bulletin Du Cancer|December 25, 2018
[Stem cell transplantation unit: Guidelines from the francophone Society of bone marrow transplantation and cellular therapy (SFGM-TC)]Catherine Faucher, Catherine Adam, Nelly Bancillon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2018
HLA-Matched Sibling versus Unrelated versus Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leukemia: A Single-Center Donor ComparisonRaynier Devillier, Faezeh Legrand, Jérôme Rey, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 26, 2019
Peripheral Blood Stem Cells versus Bone Marrow for T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Hodgkin LymphomaJacopo Mariotti, Raynier Devillier, Stefania Bramanti, et al.
Bulletin Du Cancer|May 16, 2024
[Haematopoietic stem cell donation from minor donor: Respecting laws, assessing fitness, delivering information and good care (SFGM-TC)]Marie Lejeune, Bertille Menard, Sophie Servais, et al.
Haematologica|July 17, 2010
Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI studyCatherine Cordonnier, Montserrat Rovira, Johan Maertens, et al.
Bone Marrow Transplantation|March 21, 2019
Peripheral blood stem cell for haploidentical transplantation with post-transplant high dose cyclophosphamide: detailed analysis of 181 consecutive patientsAngela Granata, Sabine Fürst, Stefania Bramanti, et al.
Cancer|August 16, 2012
Randomized study of 2 reduced-intensity conditioning strategies for human leukocyte antigen-matched, related allogeneic peripheral blood stem cell transplantation: prospective clinical and socioeconomic evaluationDidier Blaise, Reza Tabrizi, Jean-Marie Boher, et al.
Bulletin Du Cancer|November 28, 2017
[Indications and follow-up for autologous hematopoietic stem cell transplantation in autoimmune and autoinflammatory diseases: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Grégory Pugnet, Christina Castilla-Llorente, Mathieu Puyade, et al.
Blood|August 30, 2003
Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumorsDidier Blaise, Jacques Olivier Bay, Catherine Faucher, et al.
Pageof 8